Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- GPR-31 12SHETE ERK-1 2 MAPK-1 3 NF?B Hepa
- Product Overview:
GPR31, also known as the 12(S)-HETE receptor (12-HETER), is a G protein-coupled receptor that is coupled to the Gi signal transduction pathway and activated by 12(S)-HETE (Item No. 34570), a metabolite of arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607).{57788,19754} It is expressed by platelets and localizes to the plasma membrane and endoplasmic reticulum.{57788,57787} siRNA knockdown of GPR31 inhibits 12(S)-HETE-induced tumor cell invasion in vitro, and Gpr31 knockdown in murine Hepa1-6 cells reduces tumorigenesis of those cells in a mouse model of hepatocellular carcinoma recurrence after hepatic ischemia-reperfusion injury.{19754,57789} It is overexpressed in prostate cancer tumors and positively correlated with tumor grade.{57790} Cayman’s GPR31 (N-Term) Polyclonal Antibody can be used for ELISA, flow cytometry (FC), and immunofluorescence (IF) applications. The antibody recognizes the N-terminal region of GPR31 from human samples.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.